SEC Form 25-NSE filed by MISONIX, Inc.

10/29/21 9:21:22 AM ET

$MSON

Medical Specialities

Capital Goods

Get the next $MSON alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-10986

Issuer:	MISONIX INC
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1938 New Highway
	Farmingdale	NEW YORK	11735
Telephone number:				516 694-9555

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

common stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2021-10-29	By	Tara Petta		AVP
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $MSON alert in real time by email

Date

Price Target

Rating

Analyst

8/2/2021

Buy → Neutral

BTIG

7/30/2021

$23.00 → $28.00

Buy → Hold

Canaccord Genuity

SEC Form 25-NSE filed by MISONIX, Inc.

10/29/21 9:21:22 AM ET

$MSON

Medical Specialities

Capital Goods

Get the next $MSON alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-10986

Issuer:	MISONIX INC
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1938 New Highway
	Farmingdale	NEW YORK	11735
Telephone number:				516 694-9555

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

common stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2021-10-29	By	Tara Petta		AVP
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $MSON alert in real time by email

Date

Price Target

Rating

Analyst

8/2/2021

Buy → Neutral

BTIG

7/30/2021

$23.00 → $28.00

Buy → Hold

Canaccord Genuity

SEC Form 25-NSE filed by MISONIX, Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$MSON

SEC Form 25-NSE filed by MISONIX, Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$MSON

$MSON
Analyst Ratings

Misonix downgraded by BTIG

Misonix downgraded by Canaccord Genuity with a new price target

$MSON
Press Releases

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results

$MSON
Insider Trading

SEC Form 4: Koby Michael returned 1,744,017 shares to the company

SEC Form 4: Vizirgianakis Stavros G. returned 2,136,478 shares to the company, closing all direct ownership in the company

SEC Form 4: Patton Thomas M returned 104,500 shares to the company, closing all direct ownership in the company

$MSON
SEC Filings

SEC Form RW filed by MISONIX, Inc.

SEC Form 15-12B filed by MISONIX, Inc.

$MSON
Leadership Updates

Misonix Appoints Patrick J. Beyer to Board of Directors

$MSON
Financials

Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

$MSON
Large Ownership Changes

SEC Form SC 13G/A filed

SEC Form SC 13G/A filed

SEC Form 25-NSE filed by MISONIX, Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $MSON

SEC Form 25-NSE filed by MISONIX, Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $MSON

$MSON Analyst Ratings

Misonix downgraded by BTIG

Misonix downgraded by Canaccord Genuity with a new price target

$MSON Press Releases

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results

$MSON Insider Trading

SEC Form 4: Koby Michael returned 1,744,017 shares to the company

SEC Form 4: Vizirgianakis Stavros G. returned 2,136,478 shares to the company, closing all direct ownership in the company

SEC Form 4: Patton Thomas M returned 104,500 shares to the company, closing all direct ownership in the company

$MSON SEC Filings

SEC Form RW filed by MISONIX, Inc.

SEC Form 15-12B filed by MISONIX, Inc.

$MSON Leadership Updates

Misonix Appoints Patrick J. Beyer to Board of Directors

$MSON Financials

Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

$MSON Large Ownership Changes

SEC Form SC 13G/A filed

SEC Form SC 13G/A filed

Recent Analyst Ratings for
$MSON

Recent Analyst Ratings for
$MSON

$MSON
Analyst Ratings

$MSON
Press Releases

$MSON
Insider Trading

$MSON
SEC Filings

$MSON
Leadership Updates

$MSON
Financials

$MSON
Large Ownership Changes